Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues

被引:49
作者
Ferraz da Costa, Danielly C. [1 ]
Rangel, Luciana Pereira [2 ]
Duarte da Cunha Martins-Dinis, Mafalda Maria [3 ]
da Silva Ferretti, Giulia Diniz [3 ]
Ferreira, Vitor F. [4 ]
Silva, Jerson L. [3 ]
机构
[1] Univ Estado Rio de Janeiro, Inst Nutr, Dept Nutr Basica & Expt, BR-20550013 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo Meis, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941902 Rio De Janeiro, Brazil
[4] Univ Fed Fluminense, Fac Farm, Dept Tecnol Farmaceut, BR-24241000 Rio De Janeiro, Brazil
来源
MOLECULES | 2020年 / 25卷 / 04期
关键词
resveratrol; beta-lapachone; cancer; CELL-CYCLE ARREST; BREAST-CANCER CELLS; SIGNAL-TRANSDUCTION PATHWAYS; PRION-LIKE AGGREGATION; INHIBITS TUMOR-GROWTH; OXIDOREDUCTASE; NQO1; PROSTATE-CANCER; HUMAN LUNG; NAD(P)H-QUINONE OXIDOREDUCTASE; OXIDATIVE STRESS;
D O I
10.3390/molecules25040893
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review aims to explore the potential of resveratrol, a polyphenol stilbene, and beta-lapachone, a naphthoquinone, as well as their derivatives, in the development of new drug candidates for cancer. A brief history of these compounds is reviewed along with their potential effects and mechanisms of action and the most recent attempts to improve their bioavailability and potency against different types of cancer.
引用
收藏
页数:22
相关论文
共 165 条
  • [1] Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
    Alarcn de la Lastral, C.
    Villegas, I.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1156 - 1160
  • [2] Metabolic constituents of grapevine and grape-derived products
    Ali, Kashif
    Maltese, Federica
    Choi, Young Hae
    Verpoorte, Robert
    [J]. PHYTOCHEMISTRY REVIEWS, 2010, 9 (03) : 357 - 378
  • [3] Liposomal drug delivery systems: From concept to clinical applications
    Allen, Theresa M.
    Cullis, Pieter R.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 36 - 48
  • [4] The resveratrol analogue, 3,4,5,4′-trans-tetramethoxystilbene, inhibits the growth of A375 melanoma cells through multiple anticancer modes of action
    Androutsopoulos, Vasilis P.
    Fragiadaki, Irene
    Spandidos, Demetrios A.
    Tosca, Androniki
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1305 - 1314
  • [5] Growth inhibitory effects of 3′-nitro-3-phenylamino nor-beta-lapachone against HL-60: A redox-dependent mechanism
    Araujo, A. J.
    de Souza, A. A.
    da Silva Junior, E. N.
    Marinho-Filho, J. D. B.
    de Moura, M. A. B. F.
    Rocha, D. D.
    Vasconcellos, M. C.
    Costa, C. O.
    Pessoa, C.
    de Moraes, M. O.
    Ferreira, V. F.
    de Abreu, F. C.
    Pinto, A. V.
    Montenegro, R. C.
    Costa-Lotufo, L. V.
    Goulart, M. O. F.
    [J]. TOXICOLOGY IN VITRO, 2012, 26 (04) : 585 - 594
  • [6] NQO1 expression in pancreatic cancer and its potential use as a biomarker
    Awadallah, Nida S.
    Dehn, Donna
    Shah, Raj J.
    Nash, S. Russell
    Chen, Yang K.
    Ross, David
    Bentz, Joel S.
    Shroyer, Kenneth R.
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (01): : 24 - 31
  • [7] Barton BE, 2004, MOL CANCER THER, V3, P11
  • [8] Therapeutic potential of resveratrol:: the in vivo evidence
    Baur, Joseph A.
    Sinclair, David A.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) : 493 - 506
  • [9] An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone
    Bey, Erik A.
    Bentle, Melissa S.
    Reinicke, Kathryn E.
    Dong, Ying
    Yang, Chin-Rang
    Girard, Luc
    Minna, John D.
    Bornmann, William G.
    Gao, Jinming
    Boothman, David A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (28) : 11832 - 11837
  • [10] Catalase Abrogates β-Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers
    Bey, Erik A.
    Reinicke, Kathryn E.
    Srougi, Melissa C.
    Varnes, Marie
    Anderson, Vernon E.
    Pink, John J.
    Li, Long Shan
    Patel, Malina
    Cao, Lifen
    Moore, Zachary
    Rommel, Amy
    Boatman, Michael
    Lewis, Cheryl
    Euhus, David M.
    Bornmann, William G.
    Buchsbaum, Donald J.
    Spitz, Douglas R.
    Gao, Jinming
    Boothman, David A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (10) : 2110 - 2120